Recursion’s data is the world’s largest image-based dataset designed specifically for the development of machine learning algorithms in experimental biology and drug discovery. The ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature ... patient-centric target discovery, structure-based drug design including hotspot ...